ACZONE

This brand name is authorized in United States. It is also authorized in Canada, New Zealand.

Active ingredients

The drug ACZONE contains one active pharmaceutical ingredient (API):

1	Dapsone UNII 8W5C518302 - DAPSONE
	Dapsone is a sulfone active against a wide range of bacteria. Dapsones mechanism of action is probably similar to that of the sulfonamides which involves inhibition of folic acid synthesis in susceptible organisms.
	Read more about Dapsone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ACZONE Gel	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D10AX05		D Dermatologicals → D10 Anti-acne preparations → D10A Anti-acne preparations for topical use → D10AX Other anti-acne preparations for topical use
Discover more medicines within D10AX05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NZ	Medicines and Medical Devices Safety Authority	18304
US	FDA, National Drug Code	0023-3670, 0023-5206, 16110-526